Orbit Discovery
Orbit Discovery

Orbit Discovery

Fast-tracking the search for peptide drugs

Peptide-based therapies have vast potential, but finding the right candidates is complex and time-consuming.

Orbit Discovery is accelerating peptide drug discovery with its high-throughput, bead-based screening platform. Its technology enables rapid identification of functional peptides for hard-to-target disease areas, from radiopharmaceuticals to intracellular delivery – helping researchers unlock new classes of therapeutics faster.

Sector
Life Sciences
OSE Manager Limited, a wholly owned subsidiary of Oxford Science Enterprises plc, is authorised and regulated by the Financial Conduct Authority.